PHATHOM PHARMACEUTICALS, INC. (PHAT) Capital expenditures 2019–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$229,000FY2025 · since FY2019: $132,000 → $229,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $229,000 | +69.6% |
| FY2024 | $135,000 | -91.7% |
| FY2023 | $1.6M | +57.0% |
| FY2022 | $1.0M | +217.4% |
| FY2021 | $328,000 | -68.5% |
| FY2020 | $1.0M | +687.9% |
| FY2019 | $132,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice